Engene Holdings Common Etf Performance
| ENGN Etf | USD 8.69 0.08 0.91% |
The etf shows a Beta (market volatility) of 1.18, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, EnGene Holdings will likely underperform.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in enGene Holdings Common are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, EnGene Holdings displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:1 | Last Split Date 2023-11-01 |
1 | Acquisition by Ronald Cooper of 10000 shares of EnGene Holdings at 5.7 subject to Rule 16b-3 | 09/27/2024 |
2 | Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 341332 shares of EnGene Holdings at 6.338 subject to Rule 16b-3 | 09/30/2024 |
3 | engene CEO buys 57k in company shares | 10/01/2024 |
4 | Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 10153 shares of EnGene Holdings at 6.3722 subject to Rule 16b-3 | 10/02/2024 |
5 | Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 5769 shares of EnGene Holdings at 6.4824 subject to Rule 16b-3 | 10/03/2024 |
6 | Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 5997 shares of EnGene Holdings at 6.5436 subject to Rule 16b-3 | 10/04/2024 |
7 | Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 11844 shares of EnGene Holdings at 6.546 subject to Rule 16b-3 | 10/07/2024 |
8 | Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 800 shares of EnGene Holdings at 6.5981 subject to Rule 16b-3 | 10/08/2024 |
9 | enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer | 10/21/2024 |
10 | IBM Posts Weak Sales, Joins Garrett Motion, Beyond And Other Big Stocks Moving Lower In Thursdays Pre-Market Session | 10/24/2024 |
11 | Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 561797 shares of EnGene Holdings at 8.9 subject to Rule 16b-3 | 10/30/2024 |
12 | enGene to Participate in Guggenheims Inaugural Healthcare Innovation Conference | 11/05/2024 |
13 | Recent uptick might appease enGene Holdings Inc. institutional owners after losing 4.2 percent over the past year | 11/27/2024 |
| Begin Period Cash Flow | 20.4 M |
EnGene |
EnGene Holdings Relative Risk vs. Return Landscape
If you would invest 661.00 in enGene Holdings Common on September 4, 2024 and sell it today you would earn a total of 208.00 from holding enGene Holdings Common or generate 31.47% return on investment over 90 days. enGene Holdings Common is currently generating 0.5292% in daily expected returns and assumes 4.6756% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of etfs are less volatile than EnGene, and 90% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
EnGene Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EnGene Holdings' investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as enGene Holdings Common, and traders can use it to determine the average amount a EnGene Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1132
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ENGN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.68 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.53 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average EnGene Holdings is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EnGene Holdings by adding it to a well-diversified portfolio.
EnGene Holdings Fundamentals Growth
EnGene Etf prices reflect investors' perceptions of the future prospects and financial health of EnGene Holdings, and EnGene Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EnGene Etf performance.
| Return On Equity | -1.23 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 208.13 M | ||||
| Shares Outstanding | 50.98 M | ||||
| Price To Book | 1.91 X | ||||
| EBITDA | (94.77 M) | ||||
| Total Debt | 9.78 M | ||||
| Book Value Per Share | 5.21 X | ||||
| Cash Flow From Operations | (24.74 M) | ||||
| Earnings Per Share | (2.79) X | ||||
| Total Asset | 86.96 M | ||||
| Retained Earnings | (199.59 M) | ||||
About EnGene Holdings Performance
By examining EnGene Holdings' fundamental ratios, stakeholders can obtain critical insights into EnGene Holdings' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that EnGene Holdings is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
EnGene Holdings is entity of United States. It is traded as Etf on NASDAQ exchange.| EnGene Holdings appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (99.92 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| EnGene Holdings generates negative cash flow from operations | |
| Over 83.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from simplywall.st: Recent uptick might appease enGene Holdings Inc. institutional owners after losing 4.2 percent over the past year | |
| The fund retains about 97.03% of its assets under management (AUM) in fixed income securities |
Other Information on Investing in EnGene Etf
EnGene Holdings financial ratios help investors to determine whether EnGene Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EnGene with respect to the benefits of owning EnGene Holdings security.